OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

Data as of 12:37pm ET
 -0.03 / -1.49%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-12.6M-14.7M-21.1M-31.8M
Total Other Cash Flow5.6M-6.2M-4.1M-3.0M
Funds From Operations-6.9M-20.8M-25.1M-34.7M
Funds From/For Other Operating Expenses19.9M-535.0K18.4M1.3M
Net Cash Flow - Operating Activities-26.8M-20.3M-43.5M-35.9M
InvestingNet Cash Flow Investing-59.1M25.1M-21.2M32.4M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing47.5M219.0K54.2M10.0K
Exchange RateEffect of Exchange Rate on Cash-33.0K-40.0K0.009.0K
Net Change In Cash-38.5M5.0M-10.4M-3.5M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.